Furosemide EP Impurity B | CAS 2736-23-4 - Request Quote
Furosemide EP Impurity B
| SZ CAT No: | SZ-F032003 |
| CAS No | 2736-23-4 |
| Mol.F. | C7H5Cl2NO4S |
| Mol.Wt. | 270.1 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Furosemide EP Impurity B is chemically 2,4-Dichloro-5-sulfamoylbenzoic acid (as per EP). Furosemide EP Impurity B is supplied with detailed characterization data compliant with regulatory guideline. Furosemide EP Impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Furosemide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2736-23-4
Purchase 2736-23-4
Order 2736-23-4
Enquire 2736-23-4
price of 2736-23-4
2736-23-4 Supplier
2736-23-4 Manufacturer
2736-23-4 Exporter
buy high quality Furosemide EP Impurity B
Purchase Furosemide EP Impurity B
Furosemide EP Impurity B suppliers
Furosemide EP Impurity B manufacturers
Furosemide EP Impurity B price
Order Furosemide EP Impurity B
Enquire Furosemide EP Impurity B
Furosemide EP Impurity B cost
Furosemide EP Impurity B Supplier
Furosemide EP Impurity B Distributor
Furosemide EP Impurity B for Method Validation
Furosemide Reference Standard
Furosemide EP Impurity B for ANDA Filing
Furosemide EP Impurity B for Forced Degradation Studies
Furosemide EP Impurity B Identification Standards
Furosemide EP Impurity B for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.